In this current investigation, we utilized the DrugBank database to explore potential therapeutic drugs for GC, focusing on the identified hub genes (COL1A1, COL1A2, COL3A1, and FN1) as potential targets for treatment. The gene discussed is COL3A1; the disease is gastric cancer.